Health-state utilities in long-term advanced melanoma survivors comparable with the general population
{{output}}
Background: Checkpoint inhibitors have been shown to substantially improve the survival of patients with advanced melanoma. With this growing group of survivors treated with immunotherapies, assessing their health-state utilities... ...
